The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Mechanisms of Disease: metabolic effects of growth hormone and insulin-like growth factor 1
Abstract
Insulin-like growth factor (IGF) 1 is a member of a family that is involved in growth, development, cell differentiation, and metabolism. IGF1, IGF2 and insulin act primarily through tyrosine-kinase-linked receptors--the IGF1 receptor (IGF1R) and insulin receptor (IR). The IGF1R binds IGF1 and IGF2 with high affinity and the IR binds insulin with high affinity; however, since both receptors share a high degree of structural and functional homology, the IGF1R can bind insulin and the IR can bind the IGFs with reduced affinity. These two receptors can, moreover, form heterodimers, which bind both ligands. Upon binding to the receptors, cascades of tyrosine and serine kinases are stimulated to facilitate growth or metabolism. The IGF2 receptor is a scavenger receptor, and is, therefore, not involved in mediation of growth or metabolic effects of the IGF family and will not be discussed in the current article. IGF1 is a major gene target of growth hormone and its product mediates many of the actions of growth hormone on growth and development; however, IGF1 has actions distinct from those of growth hormone in carbohydrate, lipid, and protein metabolism. For example, excess growth hormone causes insulin resistance and hyperglycemia, whereas IGF1 has insulin-like effects that reduce blood glucose levels and has been used experimentally to treat both type 1 and type 2 diabetes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The effects of growth hormones on glucose regulation is intricate and changes substantially with different dosage and treatment duration (49, 51).”
From The progression of secondary diabetes: A review of modeling studies (2022) · cites this paper as [49]
In the citing paper
“on glucose regulation is intricate and changes substantially with different dosage and treatment duration (49, 51).”
From The progression of secondary diabetes: A review of modeling studies (2022) · cites this paper as [49]
In the citing paper
“The effects of growth hormones on glucose regulation is intricate and changes substantially with different dosage and treatment duration (49, 51).”
From The progression of secondary diabetes: A review of modeling studies (2022) · cites this paper as [49]
In the citing paper
“Thus, growth hormone in contrast to IGF-1 has many catabolic effects leading to provision of energy-rich substrates to an activated immune system in inflammation.”
From Interaction of the endocrine system with inflammation: a function of energy and volume regulation (2014) · cites this paper as [57]
Citations
Cites
Cellular Actions of the Insulin-Like Growth Factor Binding Proteins
Firth, S. M., & Baxter, R. C. (2002) · Endocrine Reviews · doi:10.1210/er.2001-0033 · Cited by 1,739
Effects of Human Growth Hormone in Men over 60 Years Old
Rudman, D. R., Feller, A. G., Nagraj, H. S., Gergans, G. A., Lalitha, P. Y., Goldberg, A. F., Schlenker, R. A., Cohn, L., Rudman, I. W., & Mattson, D. E. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007053230101 · Cited by 1,545
Normal growth and development in the absence of hepatic insulin-like growth factor I
Yakar, S., Liu, J., STANNARD, B. S., Butler, A. A., Accili, D., Sauer, B., & LeRoith, D. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7324 · Cited by 1,418
Self-citationIncreased mortality associated with growth hormone treatment in critically ill adults
Takala, J., Ruokonen, E., Webster, N. R., Nielsen, M. S., Zandstra, D. F., Vundelinckx, G., & Hinds, C. J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909093411102 · Cited by 1,023
INCREASED MORTALITY ASSOCIATED WITH GROWTH HORMONE TREATMENT IN CRITICALLY ILL ADULTS
Akala, J. U. T., Uokonen, E. S. R., Igel, N., Ebster, R. W., Ielsen, M. I. S. N., Andstra, D. U. F. Z., Undelinckx, G. U. V., & Inds, H. J. H. (1999) · Cited by 889
Treatment of adults with growth hormone (GH) deficiency with recombinant human GH.
Bengtsson, B. Å., Edén, S., Lönn, L., Kvist, H., Stokland, A. M., Lindstedt, G., Bosaeus, I. G., Tölli, J., Sjöström, L., & Isaksson, O. G. P. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.76.2.8432773 · Cited by 780
Roles of Growth Hormone and Insulin-like Growth Factor 1 in Mouse Postnatal Growth
Lupu, F. I., Terwilliger, J. D., Lee, K., Segre, G. V., & Efstratiadis, A. (2001) · Developmental Biology · doi:10.1006/dbio.2000.9975 · Cited by 769
Fat cell adrenergic receptors and the control of white and brown fat cell function
Lafontan, M., & Berlan, M. (1993) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37695-1 · Cited by 644
Assessment of Growth Parameters and Life Span of GHR/BP Gene-Disrupted Mice 1
Coschigano, K. T., Clemmons, D., Bellush, L. L., & Kopchick, J. J. (2000) · Endocrinology · doi:10.1210/endo.141.7.7586 · Cited by 611
Targeted Disruption of the β3-Adrenergic Receptor Gene
Susulic, V. S., Frederich, R. C., Lawitts, J. A., Tozzo, E., Kahn, B. B., Harper, M., Himms‐Hagen, J., Flier, J. S., & Lowell, B. B. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.49.29483 · Cited by 493
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 342
Matrix metalloproteinase 11 protects from diabesity and promotes metabolic switch
Dali‐Youcef, N., Hnia, K., Blaise, S. A., Messaddeq, N., Blanc, S., Postic, C., Valet, P., Tomasetto, C., & Rio, M. (2016) · Scientific Reports · doi:10.1038/srep25140 · Cited by 40
Insulin-Like Growth Factors and Insulin: At the Crossroad Between Tumor Development and Longevity
Novosyadlyy, R., & LeRoith, D. (2012) · The Journals of Gerontology Series A · doi:10.1093/gerona/gls065 · Cited by 41
Self-citationIPPD-induced growth inhibition and its mechanism in zebrafish
Zhong, L., Peng, W., Liu, C., Gao, L., Chen, D., & Duan, X. (2022) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2022.113614 · Cited by 39
Growth hormone deficiency and NAFLD: An overlooked and underrecognized link
Doycheva, I., Erickson, D. Z., & Watt, K. D. S. (2022) · Hepatology Communications · doi:10.1002/hep4.1953 · Cited by 38
D’Souza, D. R., Salib, M., Bennett, J., Mochin, M. T., Asrani, K. V., Goldblum, S. E., Renoud, K. J., Shapiro, P. S., & Passaniti, A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.002378 · Cited by 40
Identification of signaling pathways associated with cancer protection in Laron syndrome
Lapkina-Gendler, L., Rotem, I., Pasmanik‐Chor, M., Gurwitz, D., Sarfstein, R., Laron, Z., & Werner, H. (2016) · Endocrine Related Cancer · doi:10.1530/erc-16-0054 · Cited by 39
Turner, R. T., Rickard, D. J., Iwaniec, U. T., & Spelsberg, T. C. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373884-4.00057-4 · Cited by 39
Erman, A., Veilleux, A., Tchernof, A., & Goodyer, C. G. (2011) · International Journal of Obesity · doi:10.1038/ijo.2011.23 · Cited by 37
Dini, S., Zakeri, M., Ebrahimpour, S., Dehghanian, F., & Esmaeili, A. (2021) · Scientific Reports · doi:10.1038/s41598-021-87687-w · Cited by 41
Paternal Insulin-like Growth Factor 2 (Igf2) Regulates Stem Cell Activity During Adulthood
Barroca, V., Lewandowski, D., Jaracz‐Ros, A., & Hardouin, S. N. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.11.035 · Cited by 36
Li, Y., & Geng, Y. (2010) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2010.09.005 · Cited by 35
Insulin receptor isoforms are differently expressed during human osteoblastogenesis
Avnet, S., Perut, F., Salerno, M., Sciacca, L., & Baldini, N. (2012) · Differentiation · doi:10.1016/j.diff.2012.02.002 · Cited by 35
Faraji, J., Mahdavi, A., Samkhaniyan, E., Asadi, S. H., & Dezhkam, N. (2015) · Europe PMC (PubMed Central) · Cited by 35
Comparative Transcriptomic Analysis of Subcutaneous Adipose Tissue from Local Pig Breeds
Albuquerque, A., Óvilo, C., Núñez, Y., Benítez, R., López-García, A., García, F., Félix, M. D. R., Laranjo, M., Charneca, R., & Martins, J. M. (2020) · Genes · doi:10.3390/genes11040422 · Cited by 36
Hallmarks of the human intestinal microbiome on liver maturation and function
Almeida, J. I., Tenreiro, M. F., Martínez‐Santamaría, L., Guerrero‐Aspizua, S., Gisbert, J. P., Alves, P. M., Serra, M., & Baptista, P. M. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.10.015 · Cited by 37
Structural basis for assembly and disassembly of the IGF/IGFBP/ALS ternary complex
Kim, H., Fu, Y., Hong, H. J., Lee, D. S., Lee, D. S., & Kim, H. M. (2022) · Nature Communications · doi:10.1038/s41467-022-32214-2 · Cited by 35
Laron Syndrome Research Paves the Way for New Insights in Oncological Investigation
Werner, H., Sarfstein, R., Nagaraj, K., & Laron, Z. (2020) · Cells · doi:10.3390/cells9112446 · Cited by 35
Pathogenesis and remission of type 2 diabetes: what has the twin cycle hypothesis taught us?
Al-Mrabeh, A. H. (2020) · Cardiovascular Endocrinology & Metabolism · doi:10.1097/xce.0000000000000201 · Cited by 35
THE GENETIC ARCHITECTURE OF GROWTH RATE IN JUVENILETAKIFUGUSPECIES
Hosoya, S., Kai, W., Fujita, M., Miyaki, K., Suetake, H., Suzuki, Y., & Kikuchi, K. (2012) · Evolution · doi:10.1111/j.1558-5646.2012.01781.x · Cited by 31
Klotho and the Growth Hormone/Insulin-Like Growth Factor 1 Axis
Rubinek, T., & Modan‐Moses, D. (2016) · Vitamins and hormones · doi:10.1016/bs.vh.2016.02.009 · Cited by 31
Hallmarks of cancer: The insulin-like growth factors perspective
Werner, H., & LeRoith, D. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1055589 · Cited by 33
Self-citationThe production and regulation of IGF and IGFBPs in human adipose tissue cultures
Gude, M. F., Frystyk, J., Flyvbjerg, A., Bruun, J. M., Richelsen, B., & Pedersen, S. B. (2012) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2012.09.004 · Cited by 31
Insulin growth factor binding proteins as therapeutic targets in type 2 diabetes
Hjortebjerg, R., Flyvbjerg, A., & Frystyk, J. (2013) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.858698 · Cited by 30
Key‐genes regulating the liposecretion process of mature adipocytes
Maurizi, G., Petäistö, T., Maurizi, A., & Guardia, L. D. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.26188 · Cited by 30
Insulin-like growth factor- I and factors affecting it in thalassemia major
Soliman, A. T., Sanctis, V. D., Elalaily, R., & Yassin, M. A. (2014) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.131750 · Cited by 30
Giani, J. F., Bonkowski, M. S., Muñoz, M. C., Masternak, M. M., Turyn, D., Bartke, A., & Dominici, F. P. (2008) · The Journals of Gerontology Series A · doi:10.1093/gerona/63.8.788 · Cited by 29
Degen, A., Krynytska, І., & Kamyshnyi, O. (2020) · Endocrine Regulations · doi:10.2478/enr-2020-0019 · Cited by 29
Influence of Neonatal Hypothyroidism on Hepatic Gene Expression and Lipid Metabolism in Adulthood
Santana‐Farré, R., de Mirecki-Garrido, M., Bocos, C., Henríquez‐Hernández, L. A., Kahlon, N., Herrera, E., Norstedt, G., Parini, P., Flores‐Morales, A., & Fernández‐Pérez, L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037386 · Cited by 28
Hedman, C. A., Frystyk, J., Lindström, T., Oskarsson, P., & Arnqvist, H. J. (2013) · Clinical Endocrinology · doi:10.1111/cen.12296 · Cited by 28
Challenges of insulin-like growth factor-1 testing
Huang, R., Shi, J., Wei, R., & Li, J. (2024) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2024.2306804 · Cited by 27
Ciaraldi, T. P., & Sasaoka, T. (2010) · Hormone and Metabolic Research · doi:10.1055/s-0030-1267203 · Cited by 28
Rutter, M. M., Wong, B. L. Y., Collins, J. J., Sawnani, H., Taylor, M. D., Horn, P. S., & Backeljauw, P. F. (2020) · Muscle & Nerve · doi:10.1002/mus.26846 · Cited by 27
Shamardl, H. A., Ibrahim, N. A., Merzeban, D. H., Elamir, A. M., Golam, R. M., & Elsayed, A. M. (2023) · DARU Journal of Pharmaceutical Sciences · doi:10.1007/s40199-023-00458-y · Cited by 27
Unbiased approach for the identification of molecular mechanisms sensitive to chemical exposures
Suvorov, A., Salemme, V., McGaunn, J. P., Poluyanoff, A., Teffera, M., & Amir, S. (2020) · Chemosphere · doi:10.1016/j.chemosphere.2020.128362 · Cited by 24
The GH-IGF-1 Axis in Circadian Rhythm
Wang, W., Duan, X., Huang, Z., Pan, Q., Chen, C., & Guo, L. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.742294 · Cited by 30
Wang, W.-S., Du, Z.-Q., Cheng, B.-H., Wang, Y.-X., Yao, J., Li, Y.-M., Cao, Z.-P., Luan, P., Wang, N., & Li, H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117843 · Cited by 30
Elevated C-peptide and insulin predict increased risk of colorectal adenomas in normal mucosa
Vidal, A. C., Lund, P. K., Hoyo, C., Galanko, J. A., Burcal, L., Holston, R., Massa, B., Omofoye, O. A., Sandler, R. S., & Keku, T. O. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-389 · Cited by 26
van Dijk, P. R., Logtenberg, S. J. J., Chisalita, S. I., Hedman, C. A., Groenier, K. H., Gans, R. O. B., Kleefstra, N., Arnqvist, H. J., & Bilo, H. J. G. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1473 · Cited by 26
Plamper, M., Gohlke, B. C., Schreiner, F., & Woelfle, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051268 · Cited by 26
Effect of i.p. insulin administration on IGF1 and IGFBP1 in type 1 diabetes
van Dijk, P. R., Logtenberg, S. J. J., Groenier, K. H., Kleefstra, N., Bilo, H. J. G., & Arnqvist, H. J. (2013) · Endocrine Connections · doi:10.1530/ec-13-0089 · Cited by 25
Insulin-Like Growth Factor 1 in the Cardiovascular System
Aguirre, G. A., González-Guerra, J. L., Espinosa, L., & Castilla‐Cortázar, I. (2018) · Reviews of physiology, biochemistry and pharmacology · doi:10.1007/112_2017_8 · Cited by 25
Benefits of healthy adipose tissue in the treatment of diabetes
Gunawardana, S. C. (2014) · World Journal of Diabetes · doi:10.4239/wjd.v5.i4.420 · Cited by 26
Sørensen, J., Birkebæk, N., Bjerre, M., Pociot, F., Kristensen, K., Hoejberg, A. S., Frystyk, J., & the Danish Society for Diabetes in Childhood and Adolescence (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3521 · Cited by 24
Continuous subcutaneous IGF-1 therapy via insulin pump in a patient with Donohue syndrome
Weber, D. R., Stanescu, D. E., Semple, R. K., Holland, C., & Magge, S. N. (2014) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2013-0402 · Cited by 24
Ghosh, S. K., Banerjee, K. K., Vaidya, V. A., & Kolthur‐Seetharam, U. (2016) · Journal of Neuroendocrinology · doi:10.1111/jne.12397 · Cited by 23
Body size and metabolic differences in Maine Coon cats with and without hypertrophic cardiomyopathy
Freeman, L. M., Rush, J. E., Meurs, K. M., Bulmer, B. J., & Cunningham, S. M. (2012) · Journal of Feline Medicine and Surgery · doi:10.1177/1098612x12460847 · Cited by 23
Quantification of the GH/IGF-axis components: Lessons from human studies
Frystyk, J. (2011) · Domestic Animal Endocrinology · doi:10.1016/j.domaniend.2011.11.005 · Cited by 23
Jensen, R. B., Thankamony, A., O'Connell, S. M., Salgin, B., Kirk, J. M. W., Donaldson, M., Ivarsson, S. A., Söder, O., Roche, E. F., Hoey, H., et al. (2013) · Hormone Research in Paediatrics · doi:10.1159/000353438 · Cited by 23
Growth Hormone Action as a Target in Cancer: Significance, Mechanisms, and Possible Therapies
Basu, R., Boguszewski, C. L., & Kopchick, J. J. (2024) · Endocrine Reviews · doi:10.1210/endrev/bnae030 · Cited by 26
Insulin signaling in the whole spectrum of GH deficiency
Garmes, H. M., & Castillo, A. R. (2019) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000188 · Cited by 24
Ramírez-Zamudio, G. D., da Cruz, W. F. G., Schoonmaker, J. P., de Resende, F. D., Siqueira, G. R., Neto, O. R. M., Gionbelli, T. R. S., Teixeira, P. D., Rodrigues, L. M., Gionbelli, M. P., et al. (2022) · Livestock Science · doi:10.1016/j.livsci.2022.104851 · Cited by 22
Insulin-like growth factor 1 receptor mediates photoreceptor neuroprotection
Rajala, A., Teel, K., Bhat, M. A., Batushansky, A., Griffin, T. M., Purcell, L., & Rajala, R. V. S. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05074-3 · Cited by 22
Philbrook, N. A., Restivo, V. E., Belanger, C. L., & Winn, L. M. (2018) · Birth Defects Research · doi:10.1002/bdr2.1185 · Cited by 22
Pan, Y., Xie, Z., Cen, S., Li, M., Liu, W., Tang, S., Ye, G., Li, J., Guan, Z., Li, Z., et al. (2020) · Clinical and Translational Medicine · doi:10.1002/ctm2.227 · Cited by 21
Peixe, C. R., Sanchez-García, M. L., Grossman, A. B., Korbonits, M., & Marques, P. (2022) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2022.101467 · Cited by 21
Fung, C. M., Yang, Y., Fu, Q., Brown, A. S., Yu, B., Callaway, C. W., Li, J., Lane, R. H., & McKnight, R. A. (2015) · Pediatric Research · doi:10.1038/pr.2015.70 · Cited by 21
A new p.(Ile66Serfs*93) IGF2 variant is associated with pre- and postnatal growth retardation
Rockstroh, D., Pfäffle, H., Duc, D. L., Rößler, F., Schlensog‐Schuster, F., Heiker, J. T., Kratzsch, J., Kieß, W., Lemke, J. R., Jamra, R. A., et al. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0601 · Cited by 21
Ascites from patients with alcoholic liver cirrhosis contains higher IGF‐I bioactivity than serum
Jeyaratnaganthan, N., Grønbæk, H., Holland‐Fischer, P., Espelund, U. S., Chen, J., Flyvbjerg, A., Vilstrup, H., & Frystyk, J. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03707.x · Cited by 21
Nagaraj, K., Sarfstein, R., Laron, Z., & Werner, H. (2022) · Cells · doi:10.3390/cells11203260 · Cited by 20
Yang, K., Hu, Y., Feng, Y., Li, K., Zhu, Z., Liu, S., Lin, Y., & Yu, B. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-024-02970-8 · Cited by 20
Corvo, M. D., Bongiorni, S., Stefanon, B., Sgorlon, S., Valentini, A., Ajmone‐Marsan, P., & Chillemi, G. (2020) · Genes · doi:10.3390/genes11080850 · Cited by 22
Development of an UPLC/MS–MS Method for Quantification of Intact IGF-I from Human Serum
Tanna, N., Lame, M. E., & Wrona, M. D. (2019) · Bioanalysis · doi:10.4155/bio-2019-0234 · Cited by 20
Prodam, F., Savastio, S., Genoni, G., Babu, D., Giordano, M., Ricotti, R., Aimaretti, G., Bona, G., & Bellone, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087157 · Cited by 19
Chisalita, S. I., & Ludvigsson, J. (2018) · Journal of Diabetes Research · doi:10.1155/2018/8623560 · Cited by 19
Cheng, X., & Jiang, H. (2019) · Journal of International Medical Research · doi:10.1177/0300060519849295 · Cited by 19
Severe Insulin Resistance Syndromes: Clinical Spectrum and Management
Pliszka, M., & Szablewski, L. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26125669 · Cited by 21
Sex steroids and growth hormone interactions
Fernández‐Pérez, L., de Mirecki-Garrido, M., Guerra, B., Díaz, M. L., & Díaz-Chico, J. C. (2016) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2015.11.004 · Cited by 18
Yang, G., Zhao, W., Qin, C., Yang, L., Meng, X., Lu, R., Yan, X., Cao, X., Zhang, Y., & Nie, G. (2019) · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology · doi:10.1016/j.cbpb.2019.110394 · Cited by 18
Aboalola, D. A., & Han, V. K. M. (2019) · Stem Cells International · doi:10.1155/2019/9245938 · Cited by 17
Gunawardana, S. C., & Piston, D. W. (2019) · Transplantation Direct · doi:10.1097/txd.0000000000000945 · Cited by 17
Sarfstein, R., Nagaraj, K., LeRoith, D., & Werner, H. (2019) · Cells · doi:10.3390/cells8121499 · Cited by 17
Self-citationInsulin-like growth factors and aging: lessons from Laron syndrome
Werner, H., & Laron, Z. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1291812 · Cited by 16
Relationship of Body Size to Metabolic Markers and Left Ventricular Hypertrophy in Cats
Freeman, L. M., Rush, J. E., Feugier, A., & van Hoek, I. (2014) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.12503 · Cited by 16
Wlaschek, M., Maity, P., Koroma, A. K., Geiger, H., Singh, K., & Scharffetter‐Kochanek, K. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2025.03.024 · Cited by 17
Insulin resistance in NSCLC: unraveling the link between development, diagnosis, and treatment
Zhan, S., Wang, L., Wang, W., & Li, R. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1328960 · Cited by 14
Yu, A. P., Ugwu, F. N., Tam, B. T., Lee, P. H., Ma, V., Pang, S.-F., Chow, A. S., Cheng, K. K. Y., Lai, C. W. K., Wong, S. C. C., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-62271-w · Cited by 14
Widyawati, S. A., Suhartono, S., Mexitalia, M., & Soejoenoes, A. (2020) · The International Journal of Occupational and Environmental Medicine · doi:10.15171/ijoem.2020.1809 · Cited by 12
Li, M., Zhao, Y., Dai, Q., Milne, G. L., Long, J., Cai, Q., Chen, Q., Zhang, X., Qing Lan, B., Rothman, N., et al. (2022) · Obesity · doi:10.1002/oby.23408 · Cited by 13
Usuda, H., Ikeda, H., Watanabe, S., Sato, S., Fee, E. L., Carter, S. W. D., Kumagai, Y., Saito, Y., Takahashi, T., Takahashi, Y., et al. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1219185 · Cited by 13
The role of growth hormone receptor in β cell function
Wang, S., Wu, J. C., Wang, N., Zeng, L., & Wu, Y. (2017) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2017.08.002 · Cited by 13
Growth and Maturation in Development: A Fly’s Perspective
Delanoue, R., & Romero, N. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041260 · Cited by 13
Ueki, I., Giesy, S. L., Harvatine, K. J., Kim, J. W., & Boisclair, Y. R. (2009) · Endocrinology · doi:10.1210/en.2008-1740 · Cited by 13
Factors correlated with serum insulin-like growth factor-I levels in health check-up subjects
Matsumoto, R., Koga, M., Kasayama, S., Fukuoka, H., Iguchi, G., Odake, Y., Yoshida, K., Bando, H., Suda, K., Nishizawa, H., et al. (2018) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2018.01.003 · Cited by 12
Does Childhood Obesity Trigger Neuroinflammation?
Zingale, V. D., D’Angiolini, S., Chiricosta, L., Calcaterra, V., Selvaggio, G. G. O., Zuccotti, G., Destro, F., Pelizzo, G., & Mazzon, E. (2022) · Biomedicines · doi:10.3390/biomedicines10081953 · Cited by 12
Insulin-like Growth Factor-I in Growth and Metabolism
Backeljauw, P. F., Bang, P., Dunger, D. B., Juul, A., Bouc, Y. L., & Rosenfeld, R. G. (2010) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2010.23.1-2.3 · Cited by 12
Potential Synergies for Combined Targeted Therapy in the Treatment of Neuroendocrine Cancer
Salazar, R., Reidy‐Lagunes, D. L., & Yao, J. C. (2011) · Drugs · doi:10.2165/11585500-000000000-00000 · Cited by 11
Dya, G. A., Klychnikov, O. I., Adasheva, D. A., Vladychenskaya, E. A., Katrukha, A. G., & Serebryanaya, D. V. (2023) · Biochemistry (Moscow) · doi:10.1134/s0006297923140079 · Cited by 11
Acromegaly presenting with low insulin-like growth factor-1 levels and diabetes: a case report
Wijayaratne, D. R., Arambewela, M. H., Dalugama, C., Wijesundera, D., Somasundaram, N. P., & Katulanda, P. (2015) · Journal of Medical Case Reports · doi:10.1186/s13256-015-0736-z · Cited by 11
Growth and endocrine issues in children with thalassemia
Singh, P., & Seth, A. (2017) · Pediatric Hematology Oncology Journal · doi:10.1016/j.phoj.2017.12.005 · Cited by 11
Identification of ZYG11A as a candidate IGF1-dependent proto-oncogene in endometrial cancer
Achlaug, L., Sarfstein, R., Nagaraj, K., Lapkina-Gendler, L., Bruchim, I., Dixit, M., Laron, Z., Yakar, S., & Werner, H. (2019) · Oncotarget · doi:10.18632/oncotarget.27055 · Cited by 11
Self-citationIdentification of nephronectin as a new target for IGF1 action
Sarfstein, R., Lapkina-Gendler, L., Nagaraj, K., Laron, Z., & Werner, H. (2020) · European Journal of Cancer · doi:10.1016/j.ejca.2020.09.034 · Cited by 11
Emerging role of the GH/IGF-I on cardiometabolic control.
Oliveira, C. R. P., Meneguz‐Moreno, R. A., Aguiar-Oliveira, M. H., & Barreto‐Filho, J. A. (2011) · PubMed · doi:10.1590/s0066-782x2011001400012 · Cited by 11
Kwon, Y. R., Kim, Y., & Kim, Y. (2025) · Annals of Medicine · doi:10.1080/07853890.2025.2586331 · Cited by 12
Kanački, Z., Stojanovic, S., Ušćebrka, G., & Žikić, D. (2012) · Biotechnology in Animal Husbandry · doi:10.2298/bah1204797k · Cited by 10
Hesse, D., Trost, J., Schäfer, N., Schwerbel, K., Hoeflich, A., Schürmann, A., & Brockmann, G. A. (2018) · Growth Factors · doi:10.1080/08977194.2018.1497621 · Cited by 10
IGF-1 Stimulates Glycolytic ATP Production in MCF-7L Cells
Rajoria, B., Zhang, X., & Yee, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241210209 · Cited by 11
Impact of discontinuation of growth hormone treatment on lipids and weight status in adolescents
Rothermel, J., Lass, N., Bosse, C., & Reinehr, T. (2017) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2017-0098 · Cited by 10
Cohen-Sinai, T., Cohen, Z., Werner, H., & Berger, R. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00148 · Cited by 10
Sarfstein, R., & Werner, H. (2020) · Oncotarget · doi:10.18632/oncotarget.27645 · Cited by 11
Pseudo-Starvation Driven Energy Expenditure Negatively Affects Ovarian Follicle Development
Li, M., Coleman, V., Zhao, Y., Ost, M., Voigt, A., Bunschoten, A., Keijer, J., Teerds, K. J., & Klaus, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073557 · Cited by 10
Metadata
- Authors
- LeRoith, D., & Yakar, S.
- Affiliations
- Mount Sinai Hospital (US)
- Corresponding author
- LeRoith, Derek
- ORCID
- Yakar, Shoshana
- Venue
- Nature Clinical Practice Endocrinology & Metabolism
- Published
- 2007-03
- Volume
- 3
- Issue
- 3
- Pages
- 302-310
- ISSN
- 1745-8366 (ISSN-L)
- 1745-8374
- OpenAlex
- W2084967524
- Cited by
- 344
- References
- 71
- Citations by year
- 2026: 11 · 2025: 22 · 2024: 21 · 2023: 18 · 2022: 20 · 2021: 17 · 2020: 25 · 2019: 20 · 2018: 21 · 2017: 14 · 2016: 19 · 2015: 17 · 2014: 22 · 2013: 15 · 2012: 24
- FWCI
- 1.96
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Clinical Practice Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fibroblast Growth Factor Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Keywords
- insulin-like growth factor I, growth hormone, IGF-1 receptor, insulin receptor, receptor heterodimerization, tyrosine kinase signaling, insulin-like growth factor II, insulin resistance, hyperglycemia, glucose metabolism, lipid metabolism, protein metabolism, diabetes treatment
- MeSH terms
- Animals, Humans, Insulin-Like Growth Factor I, Models, Biological, Growth Hormone, Models, Animal, Growth and Development, Metabolic Networks and Pathways
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review